Matrix Metalloproteinase-9/Tissue Inhibitor of Matrix Metalloproteinase-1 Ratio is Associated with the Severity and Major Adverse Cardiovascular Event in Patients with Systolic Heart Failure

被引：0
|
作者：
Morishita, Tetsuji [1 ]
Mitsuke, Yasuhiko [1 ]
Nakano, Akira [1 ]
Uzui, Hiroyasu [1 ]
Geshi, Toru [1 ]
Amaya, Naoki [1 ]
Sarazawa, Katsuhiko [1 ]
Sato, Takehiko [1 ]
Ishida, Kentaro [1 ]
Fukuoka, Yoshitomo [1 ]
Ikeda, Hiroyuki [1 ]
Murakami, Kiwamu [1 ]
Lee, Jong-Dae [1 ]
机构：
[1] Univ Fukui Hosp, Fukui, Japan
来源：
CIRCULATION | 2011年 / 124卷 / 21期
关键词：
Heart failure; Biomarkers;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12428
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Validating Sampling Methods for Measurement of Circulating Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1
    Zhang, Ru-Yuan
    Cui, Wei
    Zhao, Kai-Jun
    Tang, Yao-Qing
    Li, Lei
    [J]. PANCREAS, 2010, 39 (06) : 937 - 937
  • [42] The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the growth type of cholangiocarcinoma.
    Park, YN
    Chae, KJ
    Koo, JS
    Oh, BK
    Rha, SY
    Yang, WI
    Choi, JS
    [J]. HEPATOLOGY, 2002, 36 (04) : 397A - 397A
  • [43] Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
    Rubanenko, O.
    Shchukin, Y.
    Rubanenko, A.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 284 - 284
  • [44] Serum matrix metalloproteinase-9:: Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma
    Bossé, M
    Chakir, J
    Rouabhia, M
    Boulet, LP
    Audette, M
    Laviolette, M
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (02) : 596 - 602
  • [45] Time course of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients presenting with acute coronary syndrome
    Bertsch, T
    Sueselbeck, T
    Wolpert, C
    Hoffmann, U
    Kaden, JJ
    Haase, KK
    Borggrefe, M
    Brueckmann, M
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (06) : 660 - 663
  • [46] Enhanced Exhalation of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Patients with COPD Exacerbation: A Prospective Study
    Kwiatkowska, S.
    Noweta, K.
    Zieba, M.
    Nowak, D.
    Bialasiewicz, P.
    [J]. RESPIRATION, 2012, 84 (03) : 231 - 241
  • [47] Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis
    Palus, Martin
    Zampachova, Eva
    Elsterova, Jana
    Ruzek, Daniel
    [J]. JOURNAL OF INFECTION, 2014, 68 (02) : 165 - 169
  • [48] IVIg decreases matrix metalloproteinase-9 production, not tissue inhibitor of metalloproteinase-1, by PBMC of multiple sclerosis patients
    Okada, K.
    Tsuji, S.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 209 - 210
  • [49] Serum Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9/Neutrophil Gelatinase-associated Lipocalin Complex Levels in Patients with Early-stage Diabetic Nephropathy
    Cakirca, Gokhan
    Turgut, Faruk Hilmi
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2018, 12 (05) : 299 - 304
  • [50] Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome
    Cheng, Min
    Hashmi, Satwat
    Mao, Xiaobo
    Zeng, Qiu Tang
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2008, 24 (05) : 385 - 390
12345